| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5942718 | Atherosclerosis | 2016 | 8 Pages |
Abstract
In addition to rescuing defective mobilization associated with diabetes, plerixafor improves the balance between EPCs and CECs, but the latter effect is blunted in patients with diabetes.
Keywords
HSCchemokine (C-X-C motif) receptor 4chemokine (C-X-C motif) ligand 12KDRCXCL12CXCR4IQRAPCCECvWFFACSAADFITCPFCEPCallophycocyaninactinomycin DRegenerationcardiovascular diseaseTherapyCirculating endothelial cellHematopoietic stem cellStem cellsEndothelial progenitor cellVon Willebrand factorgranulocyte colony-stimulating factorG-CSFphycoerythrinfluorescein isothiocyanatefluorescence activated cell sortinginterquartile rangebone marrowkinase insert domain receptor
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Roberta Cappellari, Marianna D'Anna, Angelo Avogaro, Gian Paolo Fadini,